Evidence map›Paper›PMID 39789943›Full record

ArticleThe Journal of neuropsychiatry and clinical neurosciences2025

The Population-Based Incidence and Prevalence of Catatonia.

James Luccarelli, Joshua R Smith, Mark Kalinich, Ali Amad, Jonathan P Rogers

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of neuropsychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07315386 (Catatonic Syndrome in Adult Patients at Basurto Hospital), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07315386 recruitingnot on this map

Catatonic Syndrome in Adult Patients at Basurto Hospital: A Descriptive Study of Incidence, Comorbidity, and Short-Term Outcomes

TypeobservationalSponsorBeatriz Rodriguez CaboRan2024 to 2030Enrolled40ConditionsCatatonia
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

James LuccarelliDepartment of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston (Luccarelli); Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center at Village of Vanderbilt, and Vanderbilt Kennedy Center, Vanderbilt University, Nashville (Smith); Department of Psychiatry, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston (Kalinich); Lille Neuroscience and Cognition, University of Lille, Lille, France (Amad); Division of Psychiatry, University College London, London (Rogers).
Joshua R SmithDepartment of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston (Luccarelli); Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center at Village of Vanderbilt, and Vanderbilt Kennedy Center, Vanderbilt University, Nashville (Smith); Department of Psychiatry, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston (Kalinich); Lille Neuroscience and Cognition, University of Lille, Lille, France (Amad); Division of Psychiatry, University College London, London (Rogers).
Mark KalinichDepartment of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston (Luccarelli); Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center at Village of Vanderbilt, and Vanderbilt Kennedy Center, Vanderbilt University, Nashville (Smith); Department of Psychiatry, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston (Kalinich); Lille Neuroscience and Cognition, University of Lille, Lille, France (Amad); Division of Psychiatry, University College London, London (Rogers).
Ali AmadDepartment of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston (Luccarelli); Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center at Village of Vanderbilt, and Vanderbilt Kennedy Center, Vanderbilt University, Nashville (Smith); Department of Psychiatry, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston (Kalinich); Lille Neuroscience and Cognition, University of Lille, Lille, France (Amad); Division of Psychiatry, University College London, London (Rogers).
Jonathan P RogersDepartment of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston (Luccarelli); Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center at Village of Vanderbilt, and Vanderbilt Kennedy Center, Vanderbilt University, Nashville (Smith); Department of Psychiatry, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston (Kalinich); Lille Neuroscience and Cognition, University of Lille, Lille, France (Amad); Division of Psychiatry, University College London, London (Rogers).

Funding

Translational Neuroscience Training for CliniciansT32MH112485 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BUCKNER, RANDY L, ROFFMAN, JOSHUA LAWRENCE · 2018 to 2022
$1.7M
NIMH NIH HHS T32 MH112485Wellcome Trust
6 · The paper itself

Abstract

objectiveCatatonia is a neuropsychiatric disorder that is associated with a range of medical and psychiatric illnesses. Although many single-center studies have been conducted, uncertainty over the population-based incidence and prevalence of the disorder remains. This study reports on the incidence and prevalence rates of catatonia extrapolated from two large epidemiologic studies in the United Kingdom and United States.

methodsIncidence rates (defined as the number of catatonic episodes per 100,000 person-years) and prevalence rates (defined as the proportion of individuals with catatonia in a given year) were calculated from the two studies.

resultsU.K. data showed an incidence of 4.34 (95% CI=3.98-4.72) catatonic episodes per 100,000 person-years with an average 1-year prevalence of 4.39 (95% CI=4.03-4.77) catatonic episodes per 100,000 persons. U.S. data revealed a 1-year prevalence of 5.15 (95% CI=5.08-5.23) catatonia-related hospitalizations per 100,000 persons.

conclusionsCatatonia is a rare disorder, qualifying as an orphan disease under both European Medicines Agency and U.S. Food and Drug Administration criteria. Further research is needed to rigorously define the epidemiology of catatonia in other populations.

Indexed as

CatatoniaAdolescentAdultAgedFemaleHumansIncidenceMaleMiddle AgedPrevalenceUnited KingdomUnited StatesYoung AdultCatatoniaEpidemiologyIncidenceNeuropsychiatric disordersPrevalence

Identifiers

PMID39789943
PMCPMC11996612

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.